Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.
about
History and current status of newborn screening for severe combined immunodeficiency.Use of Modeling and Simulation in the Design and Conduct of Pediatric Clinical Trials and the Optimization of Individualized Dosing Regimens.Accurately Achieving Target Busulfan Exposure in Children and Adolescents With Very Limited Sampling and the BestDose Software.Current Knowledge and Priorities for Future Research in Late Effects after Hematopoietic Stem Cell Transplantation (HCT) for Severe Combined Immunodeficiency Patients: A Consensus Statement from the Second Pediatric Blood and Marrow Transplant ConsoPrimary Immune Deficiency Treatment Consortium (PIDTC) update.Individualized conditioning regimes in cord blood transplantation: Towards improved and predictable safety and efficacy.A Nonparametric Method to Optimize Initial Drug Dosing and Attainment of a Target Exposure Interval: Concepts and Application to Busulfan in Pediatrics.Association of busulfan exposure with survival and toxicity after haemopoietic cell transplantation in children and young adults: a multicentre, retrospective cohort analysis.Test Dose Pharmacokinetics in Pediatric Patients Receiving Once-Daily IV Busulfan Conditioning for Hematopoietic Stem Cell Transplant: A Reliable Approach?Pharmacokinetics and Pharmacodynamics of Treosulfan in Patients With Thalassemia Major Undergoing Allogeneic Hematopoietic Stem Cell Transplantation.Incorporation of GSTA1 genetic variations into a population pharmacokinetic model for IV busulfan in paediatric hematopoietic stem cell transplantation.
P2860
Q35613205-CE118E4A-0334-48C3-A0C9-11795CDAA9A6Q36473125-30A4BDA9-F90A-465E-9E3C-9021CEBA080EQ36892839-C62C99E5-1D13-49ED-9540-9DC63715E66AQ38772827-AC043AE2-A727-4BEA-86C4-5EBB079AABD7Q38855061-BD1D5C19-2462-46F8-8E2A-FC25FFE25CFBQ38897538-EF7904BD-98B7-47F2-B696-718FDB8296FFQ40554814-805DA9B6-2963-41EA-AA46-6598E38DABEFQ42351682-F1954533-9902-4301-ADF7-6516A8EA6BBCQ47313046-F33083D6-E964-4E5A-9309-5F5183CA844CQ48106141-72A24690-9C69-4807-A5C6-DBA6DEDBAD3CQ52690736-5D6C4741-B7F6-416B-B37E-5CF9E4CB2FA0
P2860
Population pharmacokinetics of busulfan in pediatric and young adult patients undergoing hematopoietic cell transplant: a model-based dosing algorithm for personalized therapy and implementation into routine clinical use.
description
2015 nî lūn-bûn
@nan
2015 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Population pharmacokinetics of ...... ion into routine clinical use.
@ast
Population pharmacokinetics of ...... ion into routine clinical use.
@en
type
label
Population pharmacokinetics of ...... ion into routine clinical use.
@ast
Population pharmacokinetics of ...... ion into routine clinical use.
@en
prefLabel
Population pharmacokinetics of ...... ion into routine clinical use.
@ast
Population pharmacokinetics of ...... ion into routine clinical use.
@en
P2093
P2860
P1476
Population pharmacokinetics of ...... ion into routine clinical use.
@en
P2093
Biljana Horn
Christopher C Dvorak
Deborah French
Imke Bartelink
Janel R Long-Boyle
Lisa Musick
Morton J Cowan
Rada Savic
Shirley Yan
P2860
P304
P356
10.1097/FTD.0000000000000131
P577
2015-04-01T00:00:00Z